Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Obesity Treating Neuromodulation System market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Obesity Treating Neuromodulation System market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Obesity Treating Neuromodulation System market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Obesity Treating Neuromodulation System products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Obesity Treating Neuromodulation System products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Obesity Treating Neuromodulation System market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Obesity Treating Neuromodulation System development has been the leading industry trend of Obesity Treating Neuromodulation System market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Obesity Treating Neuromodulation System Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
Report Attributes |
Details |
The market size value in 2021 |
USD XX.XX Million |
CAGR (2021 - 2028) |
XX.XX % |
The Revenue forecast in 2028 |
USD XX.XX Million |
Base year for estimation |
2021 |
Historical data |
2018-2019 |
Forecast period |
2022-2028 |
Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
By Type Outlook |
Vagus Nerve Stimulator,Splanchnic Nerve Stimulator,Deep Brain Stimulator,Spinal Cord Stimulator,Autonomous Nerve Stimulator,Others |
By Application Outlook |
Hospitals,Clinics,Ambulatory Surgical Centers, Other |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled |
Medtronic,Cyberonics,St. Jude Medical,BioControl Medical,Leptos Medical,EnteroMedics,Nevro,Nuvectra |
Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Medtronic
- Cyberonics
- St. Jude Medical
- BioControl Medical
- Leptos Medical
- EnteroMedics
- Nevro
- Nuvectra
Obesity Treating Neuromodulation System Market, By Type
- Vagus Nerve Stimulator
- Splanchnic Nerve Stimulator
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Autonomous Nerve Stimulator
- Others
Obesity Treating Neuromodulation System Market, By Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Obesity Treating Neuromodulation System Market Size Growth Rate by Type (2019-2025)
1.3.2 Vagus Nerve Stimulator
1.3.3 Splanchnic Nerve Stimulator
1.3.4 Deep Brain Stimulator
1.3.5 Spinal Cord Stimulator
1.3.6 Autonomous Nerve Stimulator
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Obesity Treating Neuromodulation System Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Obesity Treating Neuromodulation System Production Value 2014-2025
2.1.2 Global Obesity Treating Neuromodulation System Production 2014-2025
2.1.3 Global Obesity Treating Neuromodulation System Capacity 2014-2025
2.1.4 Global Obesity Treating Neuromodulation System Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Obesity Treating Neuromodulation System Market Size CAGR of Key Regions
2.2.2 Global Obesity Treating Neuromodulation System Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Obesity Treating Neuromodulation System Capacity by Manufacturers
3.1.2 Global Obesity Treating Neuromodulation System Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Obesity Treating Neuromodulation System Revenue by Manufacturers (2014-2019)
3.2.2 Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Obesity Treating Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.3 Obesity Treating Neuromodulation System Price by Manufacturers
3.4 Key Manufacturers Obesity Treating Neuromodulation System Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Obesity Treating Neuromodulation System Market
3.6 Key Manufacturers Obesity Treating Neuromodulation System Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Vagus Nerve Stimulator Production and Production Value (2014-2019)
4.1.2 Splanchnic Nerve Stimulator Production and Production Value (2014-2019)
4.1.3 Deep Brain Stimulator Production and Production Value (2014-2019)
4.1.4 Spinal Cord Stimulator Production and Production Value (2014-2019)
4.1.5 Autonomous Nerve Stimulator Production and Production Value (2014-2019)
4.1.6 Others Production and Production Value (2014-2019)
4.2 Global Obesity Treating Neuromodulation System Production Market Share by Type
4.3 Global Obesity Treating Neuromodulation System Production Value Market Share by Type
4.4 Obesity Treating Neuromodulation System Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Obesity Treating Neuromodulation System Consumption by Application
6 Production by Regions
6.1 Global Obesity Treating Neuromodulation System Production (History Data) by Regions 2014-2019
6.2 Global Obesity Treating Neuromodulation System Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Obesity Treating Neuromodulation System Production Growth Rate 2014-2019
6.3.2 United States Obesity Treating Neuromodulation System Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Obesity Treating Neuromodulation System Import & Export
6.4 European Union
6.4.1 European Union Obesity Treating Neuromodulation System Production Growth Rate 2014-2019
6.4.2 European Union Obesity Treating Neuromodulation System Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Obesity Treating Neuromodulation System Import & Export
6.5 China
6.5.1 China Obesity Treating Neuromodulation System Production Growth Rate 2014-2019
6.5.2 China Obesity Treating Neuromodulation System Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Obesity Treating Neuromodulation System Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Obesity Treating Neuromodulation System Consumption by Regions
7.1 Global Obesity Treating Neuromodulation System Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Obesity Treating Neuromodulation System Consumption by Type
7.2.2 United States Obesity Treating Neuromodulation System Consumption by Application
7.3 European Union
7.3.1 European Union Obesity Treating Neuromodulation System Consumption by Type
7.3.2 European Union Obesity Treating Neuromodulation System Consumption by Application
7.4 China
7.4.1 China Obesity Treating Neuromodulation System Consumption by Type
7.4.2 China Obesity Treating Neuromodulation System Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Obesity Treating Neuromodulation System Consumption by Type
7.5.2 Rest of World Obesity Treating Neuromodulation System Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Obesity Treating Neuromodulation System
8.1.4 Obesity Treating Neuromodulation System Product Introduction
8.1.5 Medtronic Recent Development
8.2 Cyberonics
8.2.1 Cyberonics Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Obesity Treating Neuromodulation System
8.2.4 Obesity Treating Neuromodulation System Product Introduction
8.2.5 Cyberonics Recent Development
8.3 St. Jude Medical
8.3.1 St. Jude Medical Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Obesity Treating Neuromodulation System
8.3.4 Obesity Treating Neuromodulation System Product Introduction
8.3.5 St. Jude Medical Recent Development
8.4 BioControl Medical
8.4.1 BioControl Medical Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Obesity Treating Neuromodulation System
8.4.4 Obesity Treating Neuromodulation System Product Introduction
8.4.5 BioControl Medical Recent Development
8.5 Leptos Medical
8.5.1 Leptos Medical Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Obesity Treating Neuromodulation System
8.5.4 Obesity Treating Neuromodulation System Product Introduction
8.5.5 Leptos Medical Recent Development
8.6 EnteroMedics
8.6.1 EnteroMedics Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Obesity Treating Neuromodulation System
8.6.4 Obesity Treating Neuromodulation System Product Introduction
8.6.5 EnteroMedics Recent Development
8.7 Nevro
8.7.1 Nevro Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Obesity Treating Neuromodulation System
8.7.4 Obesity Treating Neuromodulation System Product Introduction
8.7.5 Nevro Recent Development
8.8 Nuvectra
8.8.1 Nuvectra Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Obesity Treating Neuromodulation System
8.8.4 Obesity Treating Neuromodulation System Product Introduction
8.8.5 Nuvectra Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Obesity Treating Neuromodulation System Capacity, Production Forecast 2019-2025
9.1.2 Global Obesity Treating Neuromodulation System Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Obesity Treating Neuromodulation System Production and Value Forecast by Regions 2019-2025
9.2.2 Global Obesity Treating Neuromodulation System Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Obesity Treating Neuromodulation System Production Forecast by Type
9.7.2 Global Obesity Treating Neuromodulation System Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Obesity Treating Neuromodulation System Sales Channels
10.2.2 Obesity Treating Neuromodulation System Distributors
10.3 Obesity Treating Neuromodulation System Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer